Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 19/20 | 0.49 |
| ▸ | AKT2 | P31751 | 19/20 | 0.49 |
| ▸ | AKT3 | Q9Y243 | 19/20 | 0.49 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.40 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2553819 | 0.86 | AKT1 (0.50) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2559471 | 0.86 | AKT1 (0.50) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2556580 | 0.81 | AKT1 (0.52) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2555640 | 0.80 | AKT1 (0.51) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2556234 | 0.80 | AKT1 (0.61) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2549603 | 0.80 | AKT1 (0.51) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL29822294 | 0.79 | AKT1 (0.67) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL191314 | 0.79 | AKT1 (0.67) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL191315 | 0.79 | AKT1 (0.67) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL15973930 | 0.78 | AKT1 (0.54) | AKT1AKT2AKT3PIK3CAPRKG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2558864-A1 | FOX03A AS PREDICTIVE BIOMARKER FOR PI3K/AKT KINASE PATHWAY INHIBITOR EFFICACY | Genentech, Inc. (US) | 2013-02-20 | — | — | EP | disclosed |
| WO-2011130654-A1 | FOX03A AS PREDICTIVE BIOMARKER FOR PI3K/AKT KINASE PATHWAY INHIBITOR EFFICACY | GENENTECH, INC. (US) | 2011-10-20 | — | — | WO | disclosed |